| Involvement of heparanase in the pathogenesis of mesothelioma: basic aspects and clinical applications U Barash, M Lapidot, Y Zohar, C Loomis, A Moreira, S Feld, C Goparaju, ... JNCI: Journal of the National Cancer Institute 110 (10), 1102-1114, 2018 | 47 | 2018 |
| Pleurectomy decortication in the treatment of malignant pleural mesothelioma: encouraging results and novel prognostic implications based on experience in 355 consecutive patients M Lapidot, RR Gill, E Mazzola, S Freyaldenhoven, SJ Swanson, ... Annals of Surgery 275 (6), 1212-1220, 2022 | 33 | 2022 |
| Inhibitors of the transcription factor STAT3 decrease growth and induce immune response genes in models of malignant pleural mesothelioma (MPM) M Lapidot, AE Case, D Larios, HI Gandler, C Meng, I Tošić, EL Weisberg, ... Cancers 13 (1), 7, 2020 | 18 | 2020 |
| Aberrant right subclavian artery-suggested mechanism for esophageal foreign body impaction: Case report E Brauner, M Lapidot, R Kremer, LA Best, Y Kluger World Journal of Emergency Surgery 6, 1-3, 2011 | 15 | 2011 |
| Progress of malignant mesothelioma research in basic science: a review of the 14th international conference of the international mesothelioma interest group (iMig2018) L Wu, I Dell'Anno, M Lapidot, Y Sekido, ML Chan, M Kohno, ... Lung Cancer 127, 138-145, 2019 | 14 | 2019 |
| Airway reactivity in children before and after stem cell transplantation L Bentur, M Lapidot, G Livnat, F Hakim, C Lidroneta‐Katz, I Porat, ... Pediatric pulmonology 44 (9), 845-850, 2009 | 13 | 2009 |
| Coordinate activation of a target gene by KDM1C histone demethylase and OTLD1 histone deubiquitinase in Arabidopsis I Keren, M Lapidot, V Citovsky Epigenetics 14 (6), 602-610, 2019 | 11 | 2019 |
| Postoperative empyema after pleurectomy decortication for malignant pleural mesothelioma M Lapidot, E Mazzola, S Freyaldenhoven, LE De León, MT Jaklitsch, ... The Annals of Thoracic Surgery 114 (4), 1214-1219, 2022 | 10 | 2022 |
| Novel therapeutic targets and immune dysfunction in malignant pleural mesothelioma M Lapidot, SV Saladi, R Salgia, M Sattler Frontiers in Pharmacology 12, 806570, 2022 | 10 | 2022 |
| New concepts in the treatment of malignant pleural mesothelioma M Lapidot, S Freyaldenhoven, R Bueno Journal of Thoracic Disease 10 (3), 2018 | 10 | 2018 |
| Streptokinase fibrinolysis protocol: The advantages of a non-operative treatment for stage II pediatric empyema patients DL Faber, LA Best, M Orlovsky, M Lapidot, RR Nir, R Kremer Isr Med Assoc J 14 (3), 157-161, 2012 | 10 | 2012 |
| Outcomes of pleurectomy decortication in patients with biphasic mesothelioma M Lapidot, E Mazzola, R Bueno The Journal of Thoracic and Cardiovascular Surgery 164 (5), 1340-1348. e3, 2022 | 9 | 2022 |
| Involvement of heparanase in empyema: implication for novel therapeutic approaches M Lapidot, U Barash, Y Zohar, Y Geffen, I Naroditsky, N Ilan, LA Best, ... Journal of clinical & cellular immunology 6 (1), 2015 | 9 | 2015 |
| Essential role of the histone lysine demethylase KDM4A in the biology of malignant pleural mesothelioma (MPM) M Lapidot, AE Case, EL Weisberg, C Meng, SR Walker, S Garg, W Ni, ... British Journal of Cancer 125 (4), 582-592, 2021 | 8 | 2021 |
| Pericardial effusion due to primary malignant pericardial mesothelioma: a common finding but an uncommon cause V Istomin, DS Blondheim, SR Meisel, A Frimerman, M Lapidot, ... Case Reports in Medicine 2016 (1), 4810901, 2016 | 8 | 2016 |
| Routine surveillance for diagnosis of venous thromboembolism after pleurectomy for malignant pleural mesothelioma LE De León, CE Bravo-Iñiguez, S Fox, J Tarascio, S Freyaldenhoven, ... The Journal of thoracic and cardiovascular surgery 160 (4), 1064-1073, 2020 | 6 | 2020 |
| Heparanase inhibitors restrain mesothelioma M Lapidot, U Barash, I Vlodavsky, H Pass Oncotarget 9 (96), 36830, 2018 | 5 | 2018 |
| C-Reactive Protein Predicts Pleurodesis Success in Malignant Pleural Effusion Patients. M Lapidot, DL Faber, RR Nir, M Orlovsky, M Kagan, LA Best, R Kremer Journal of Palliative Medicine 16 (4), 2013 | 3 | 2013 |
| Prolonged air leak after lung surgery—prevalent complication without a perfect solution M Lapidot, DL Faber, R Bueno J. Thorac. Dis 15, 5285-5286, 2023 | 2 | 2023 |
| Pleurectomy decortication is the preferred surgical procedure in pleural mesothelioma M Lapidot, R Bueno Transl Lung Cancer Res 12, 190-2, 2023 | 2 | 2023 |
Emanuele MazzolaDana-Farber Cancer Institute在 jimmy.harvard.edu 的电子邮件经过验证
